Tabak AG, Herder C, Rathmann W, Brunner EJ, Kivimaki M. Prediabetes: a high-risk state for diabetes development. Lancet. 2012;379(9833):2279–90.
Article PubMed PubMed Central Google Scholar
International Diabetes Federation. IDF Diabetes Atlas 10th edition. [Accessed 2023 Aug 28]. https://diabetesatlas.org/en/resources/…
Rooney MR, Fang M, Ogurtsova K, Ozkan B, Echouffo-Tcheugui JB, Boyko EJ, Magliano DJ, Selvin E. Global prevalence of Prediabetes. Diabetes Care. 2023;46(7):1388–94.
Article CAS PubMed PubMed Central Google Scholar
Porrini E, Diaz JM, Moreso F, Lauzurrica R, Ibernon M, Torres IS, Ruiz RB, Rodriguez RA, Mallen PD, Bayes-Genis B, et al. Prediabetes is a risk factor for cardiovascular disease following renal transplantation. KIDNEY INT. 2019;96(6):1374–80.
Huang Y, Cai X, Mai W, Li M, Hu Y. Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis. BMJ-BRIT MED J. 2016;355:i5953.
Wang A, Zhang J, Zuo Y, Tian X, Chen S, Wu S, Zhao X, Wang Y. Prediabetes and risk of stroke and its subtypes by hypertension status. DIABETES-METAB RES. 2022;38(4):e3521.
Hubbard D, Colantonio LD, Tanner RM, Carson AP, Sakhuja S, Jaeger BC, Carey RM, Cohen LP, Shimbo D, Butler M, et al. Prediabetes and Risk for Cardiovascular Disease by Hypertension Status in black adults: the Jackson Heart Study. Diabetes Care. 2019;42(12):2322–9.
Article PubMed PubMed Central Google Scholar
Busquets-Cortes C, Bennasar-Veny M, Lopez-Gonzalez AA, Fresneda S, Abbate M, Yanez AM. Utility of fatty liver index to predict reversion to normoglycemia in people with prediabetes. PLoS ONE. 2021;16(4):e249221.
Perreault L, Pan Q, Mather KJ, Watson KE, Hamman RF, Kahn SE. Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the diabetes Prevention Program outcomes Study. Lancet. 2012;379(9833):2243–51.
Article CAS PubMed PubMed Central Google Scholar
Liu X, Wu S, Song Q, Wang X. Reversion from Pre-diabetes Mellitus to Normoglycemia and Risk of Cardiovascular Disease and all-cause mortality in a Chinese Population: a prospective cohort study. J AM HEART ASSOC. 2021;10(3):e19045.
Chen Y, Zhang P, Wang J, Gong Q, An Y, Qian X, Zhang B, Li H, Gregg EW, Bennett PH et al. Associations of progression to diabetes and regression to normal glucose tolerance with development of cardiovascular and microvascular disease among people with impaired glucose tolerance: a secondary analysis of the 30 year Da Qing Diabetes Prevention Outcome Study. DIABETOLOGIA 2021, 64(6):1279–1287.
Amer OE, Sabico S, Alfawaz HA, Aljohani N, Hussain SD, Alnaami AM, Wani K, Al-Daghri NM. Reversal of Prediabetes in Saudi Adults: Results from an 18 Month Lifestyle Intervention. NUTRIENTS 2020, 12(3):804.
Knowler WC, Barrett-Connor E, Fowler SE, Hamman RF, Lachin JM, Walker EA, Nathan DM. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. NEW ENGL J MED. 2002;346(6):393–403.
Article CAS PubMed Google Scholar
Ginsberg HN, Packard CJ, Chapman MJ, Boren J, Aguilar-Salinas CA, Averna M, Ference BA, Gaudet D, Hegele RA, Kersten S, et al. Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society. EUR HEART J. 2021;42(47):4791–806.
Article CAS PubMed PubMed Central Google Scholar
Nordestgaard BG: Triglyceride-Rich Lipoproteins and Atherosclerotic Cardiovascular Disease: New Insights From Epidemiology, Genetics, and, Biology. CIRC RES 2016, 118(4):547–563.
Wang K, Wang R, Yang J, Liu X, Shen H, Sun Y, Zhou Y, Fang Z, Ge H. Remnant cholesterol and atherosclerotic cardiovascular disease: metabolism, mechanism, evidence, and treatment. FRONT CARDIOVASC MED. 2022;9:913869.
Article CAS PubMed PubMed Central Google Scholar
Burnett JR, Hooper AJ, Hegele RA. Remnant cholesterol and atherosclerotic Cardiovascular Disease Risk. J AM COLL CARDIOL. 2020;76(23):2736–9.
Article CAS PubMed Google Scholar
Quispe R, Martin SS, Michos ED, Lamba I, Blumenthal RS, Saeed A, Lima J, Puri R, Nomura S, Tsai M, et al. Remnant cholesterol predicts cardiovascular disease beyond LDL and ApoB: a primary prevention study. EUR HEART J. 2021;42(42):4324–32.
Article CAS PubMed PubMed Central Google Scholar
Chen AH, Tseng CH. The role of triglyceride in cardiovascular disease in Asian patients with type 2 diabetes–a systematic review. Rev Diabet Stud. 2013;10(2–3):101–9.
Article CAS PubMed PubMed Central Google Scholar
Tseng CH, Tseng CP, Chong CK, Cheng JC, Tai TY. Independent association between triglycerides and coronary artery disease in Taiwanese type 2 diabetic patients. INT J CARDIOL. 2006;111(1):80–5.
Tai TY, Tseng CH, Sung SM, Huang RF, Chen CZ, Tsai SH. Retinopathy, neuropathy and nephropathy in non-insulin-dependent diabetic patients. J FORMOS MED ASSOC. 1991;90(10):936–40.
Tseng CH. Lipid abnormalities associated with urinary albumin excretion rate in Taiwanese type 2 diabetic patients. KIDNEY INT. 2005;67(4):1547–53.
Article CAS PubMed Google Scholar
Tseng CH, Tseng CP, Chong CK. Joint effects of hypertension, smoking, dyslipidemia and obesity and angiotensin-converting enzyme DD genotype on albuminuria in Taiwanese patients with type 2 diabetes mellitus. CLIN BIOCHEM. 2010;43(7–8):629–34.
Article CAS PubMed Google Scholar
Zou Y, Kuang M, Zhong Y, Jiang C. Remnant cholesterol can identify individuals at higher risk of metabolic syndrome in the general population. SCI REP-UK. 2023;13(1):5957.
Ohnishi H, Saitoh S, Takagi S, Ohata J, Isobe T, Kikuchi Y, Takeuchi H, Shimamoto K. Relationship between insulin-resistance and remnant-like particle cholesterol. ATHEROSCLEROSIS. 2002;164(1):167–70.
Article CAS PubMed Google Scholar
Klop B, Elte JW, Cabezas MC. Dyslipidemia in obesity: mechanisms and potential targets. NUTRIENTS. 2013;5(4):1218–40.
Article CAS PubMed PubMed Central Google Scholar
Huh JH, Roh E, Lee SJ, Ihm SH, Han KD, Kang JG. Remnant cholesterol is an independent predictor of type 2 diabetes: a Nationwide Population-based Cohort Study. Diabetes Care. 2023;46(2):305–12.
Article CAS PubMed Google Scholar
Xie G, Zhong Y, Yang S, Zou Y. Remnant cholesterol is an independent predictor of New-Onset diabetes: a single-Center Cohort Study. DIABET METAB SYND OB. 2021;14:4735–45.
Zheng X, Jiang M, Ren X, Han L. The longitudinal association of remnant cholesterol with diabetes in middle-aged and elderly Chinese: a nationwide population-based cohort study. J DIABETES COMPLICAT. 2023;37(1):108360.
Carvalho L, Bensenor IM, Nogueira A, Duncan BB, Schmidt MI, Blaha MJ, Toth PP, Jones SR, Santos RD, Lotufo PA, et al. Increased particle size of triacylglycerol-enriched remnant lipoproteins, but not their plasma concentration or lipid content, augments risk prediction of incident type 2 diabetes. Diabetologia. 2021;64(2):385–96.
Article CAS PubMed Google Scholar
Chen Y, Zhang XP, Yuan J, Cai B, Wang XL, Wu XL, Zhang YH, Zhang XY, Yin T, Zhu XH, et al. Association of body mass index and age with incident diabetes in Chinese adults: a population-based cohort study. BMJ OPEN. 2018;8(9):e21768.
Chen Y, et al. Data from: Association of body mass index and age withincident diabetes in Chinese adults: a population-based cohort study Dryad. Dataset. 2018. https://doi.org/10.5061/dryad.ft8750v.
Nordestgaard BG, Varbo A. Triglycerides and cardiovascular disease. Lancet. 2014;384(9943):626–35.
Article CAS PubMed Google Scholar
Classification and Diagnosis of Diabetes. Standards of Medical Care in Diabetes-2022. Diabetes Care. 2022;45(Suppl 1):S17–38.
White IR, Royston P, Wood AM. Multiple imputation using chained equations: issues and guidance for practice. STAT MED. 2011;30(4):377–99.
Comments (0)